Cargando…
Structure-based development of specific inhibitors for individual cathepsins and their medical applications
Specific inhibitors for individual cathepsins have been developed based on their tertiary structures of X-ray crystallography. Cathepsin B-specific inhibitors, CA-074 and CA-030, and cathepsin L specific inhibitors, CLIK-148 and CLIK-195, were designed as the epoxysuccinate derivatives. Cathepsin S...
Autor principal: | KATUNUMA, Nobuhiko |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Japan Academy
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043741/ https://www.ncbi.nlm.nih.gov/pubmed/21321479 http://dx.doi.org/10.2183/pjab.87.29 |
Ejemplares similares
-
Posttranslational Processing and Modification of Cathepsins and Cystatins
por: Katunuma, Nobuhiko
Publicado: (2010) -
An Active 32-kDa Cathepsin L Is Secreted Directly from HT 1080 Fibrosarcoma Cells and Not via Lysosomal Exocytosis
por: Hashimoto, Yoko, et al.
Publicado: (2015) -
Cathepsin L Inhibition Prevents Murine Autoimmune Diabetes via Suppression of CD8(+) T Cell Activity
por: Yamada, Akiko, et al.
Publicado: (2010) -
Cathepsin L is required for ecotropic murine leukemia virus infection in NIH3T3 cells
por: Yoshii, Hiroaki, et al.
Publicado: (2009) -
CD4-Independent Human Immunodeficiency Virus Infection Involves Participation of Endocytosis and Cathepsin B
por: Yoshii, Hiroaki, et al.
Publicado: (2011)